Eric Ferrandis

952 citations

27 papers · 761 indexed · h-index 16

Impact in

Toxicology top 5%
Organic Chemistry top 10%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Quinazolinone synthesis and applications

Papers in ⓘ

Molecular Biology 11
- Cancer therapeutics and mechanisms 3
Organic Chemistry 10
- Synthesis and Biological Evaluation 6
- Ferrocene Chemistry and Applications 3
- Synthesis and biological activity 3

Co-authors: Barry V. L. Potter (13 shared papers)Mathew P. Leese (13 shared papers)Fabrice Jourdan (12 shared papers)Atul Purohit (9 shared papers)Wolfgang Döhle (8 shared papers)Ernest Hamel (7 shared papers)Simon P. Newman (8 shared papers)Michael Reed (7 shared papers)
Journals: Journal of Medicinal Chemistry (5 papers)ChemMedChem (4 papers)Nature Medicine (1 paper)Chemical Communications (1 paper)British Journal of Cancer (1 paper)
Partner nations: France United Kingdom United States

In The Last Decade

Eric Ferrandis

26 papers receiving 755 citations

Peers

Countries citing papers authored by Eric Ferrandis

Since Specialization

Citations

This map shows the geographic impact of Eric Ferrandis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Ferrandis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Ferrandis more than expected).

Fields of papers citing papers by Eric Ferrandis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Ferrandis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Ferrandis. The network helps show where Eric Ferrandis may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric Ferrandis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric Ferrandis Line = papers co-authored together Eric Ferrandis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure Journal of Medicinal Chemistry ·Wolfgang Döhle, Fabrice Jourdan, Grégory Menchon, A.E. Prota, Paul Foster, Pascoe Mannion, Ernest Hamel, Mark Thomas, Philip G. Kasprzyk, Eric Ferrandis, Michel O. Steinmetz, Mathew P. Leese, Barry V. L. Potter	2017	111
2	Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells. Molecular Pharmacology ·Catherine Müller, F Goubin, Eric Ferrandis, I Cornil-Scharwtz, Jean‐Denis Bailly, Cécile Bordier, Julie Bénard, Branimir I. Šikić, G Laurent	1995	63
3	Inhibition of Heterotrimeric G Protein Signaling by a Small Molecule Acting on Gα Subunit Journal of Biological Chemistry ·Mohammed Akli Ayoub, Marjorie Damian, Christian Gespach, Eric Ferrandis, Olivier Lavergne, Olivier De Wever, Jean‐Louis Banères, Jean‐Philippe Pin, Grégoire Prévost	2009	61
4	Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse. PubMed ·Eric Ferrandis, J. Da Silva, G Riou, I Bénard	1994	56
5	3,17-Disubstituted 2-Alkylestra-1,3,5(10)-trien-3-ol Derivatives: Synthesis, In Vitro and In Vivo Anticancer Activity Journal of Medicinal Chemistry ·Christian Bubert, Mathew P. Leese, Mary F. Mahon, Eric Ferrandis, Sandra Regis-Lydi, Philip G. Kasprzyk, Simon P. Newman, Yaik T. Ho, Atul Purohit, Michael Reed, Barry V. L. Potter	2007	53
6	Structure–Activity Relationships of C-17 Cyano-Substituted Estratrienes as Anticancer Agents Journal of Medicinal Chemistry ·Mathew P. Leese, Fabrice Jourdan, Keira Gaukroger, Mary F. Mahon, Simon P. Newman, Paul Foster, Chloe Stengel, Sandra Regis-Lydi, Eric Ferrandis, Anna Di Fiore, Giuseppina De Simone, Claudiu T. Supuran, Atul Purohit, Michael Reed, Barry V. L. Potter	2008	49
7	Novel inhibitors of 17β-hydroxysteroid dehydrogenase type 1: Templates for design Bioorganic & Medicinal Chemistry ·G.M. Allan, Nigel Vicker, Harshani R. Lawrence, Helena J. Tutill, Joanna M. Day, Marion Huchet, Eric Ferrandis, Michael Reed, Atul Purohit, Barry V. L. Potter	2008	38
8	Synthesis, Antitubulin, and Antiproliferative SAR of Analogues of 2-Methoxyestradiol-3,17-O,O-bis-sulfamate Journal of Medicinal Chemistry ·Fabrice Jourdan, Mathew P. Leese, Wolfgang Döhle, Ernest Hamel, Eric Ferrandis, Simon P. Newman, Atul Purohit, Michael Reed, Barry V. L. Potter	2010	37
9	MYCN Enhances P-gp/MDR1 Gene Expression in the Human Metastatic Neuroblastoma IGR-N-91 Model American Journal Of Pathology ·Étienne Blanc, David Goldschneider, Eric Ferrandis, Michel Barrois, G. Le Roux, Stéphane Léonce, Sétha Douc‐Rasy, Jean Bénard, Gilda Raguénez	2003	34
10	Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling Organic & Biomolecular Chemistry ·Fabrice Jourdan, Christian Bubert, Mathew P. Leese, Andrew Smith, Eric Ferrandis, Sandra Regis-Lydi, Simon P. Newman, Atul Purohit, Michael Reed, Barry V. L. Potter	2008	30
11	Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors ACS Medicinal Chemistry Letters ·Mathew P. Leese, Fabrice Jourdan, Wolfgang Döhle, Meriel R. Kimberley, Mark Thomas, Ruoli Bai, Ernest Hamel, Eric Ferrandis, Barry V. L. Potter	2011	27
12	A ligand-receptor fusion of growth hormone forms a dimer and is a potent long-acting agonist Nature Medicine ·Ian Wilkinson, Eric Ferrandis, Peter J. Artymiuk, Marc Teillot, C. Soulard, Caroline Touvay, Sarbendra Pradhananga, S Justice, Zida Wu, K C Leung, Christian J. Strasburger, Jon R. Sayers, Richard Ross	2007	26
13	Chimeric microtubule disruptors Chemical Communications ·Mathew P. Leese, Fabrice Jourdan, Meriel R. Kimberley, Gyles E. Cozier, Nethaji Thiyagarajan, Chloe Stengel, Sandra Regis-Lydi, Paul Foster, Simon P. Newman, K. Ravi Acharya, Eric Ferrandis, Atul Purohit, Michael Reed, Barry V. L. Potter	2010	25
14	Structure–Activity Relationships of C-17-Substituted Estratriene-3-O-sulfamates as Anticancer Agents Journal of Medicinal Chemistry ·Fabrice Jourdan, Mathew P. Leese, Wolfgang Döhle, Eric Ferrandis, Simon P. Newman, Surinder K. Chander, Atul Purohit, Barry V. L. Potter	2011	21
15	Synthesis, Anti‐tubulin and Antiproliferative SAR of Steroidomimetic Dihydroisoquinolinones ChemMedChem ·Mathew P. Leese, Fabrice Jourdan, Meriel R. Major, Wolfgang Döhle, Mark Thomas, Ernest Hamel, Eric Ferrandis, Mary F. Mahon, Simon P. Newman, Atul Purohit, Barry V. L. Potter	2014	16
16	Prognostic value of MDR1 gene expression in neuroblastoma: results of a multivariate analysis. PubMed ·Jean Bénard, Jean Bourhis, Florent de Vathaire, Eric Ferrandis, Terrier-Lacombe Mj, J Lemerle, G Riou, Oliver Hartmann	1994	16
17	Synthesis, Antitubulin, and Antiproliferative SAR of C3/C1‐Substituted Tetrahydroisoquinolines ChemMedChem ·Wolfgang Döhle, Mathew P. Leese, Fabrice Jourdan, Meriel R. Major, Ruoli Bai, Ernest Hamel, Eric Ferrandis, Philip G. Kasprzyk, Ann Fiore, Simon P. Newman, Atul Purohit, Barry V. L. Potter	2014	15
18	Tetrahydroisoquinolinone‐Based Steroidomimetic and Chimeric Microtubule Disruptors ChemMedChem ·Mathew P. Leese, Fabrice Jourdan, Meriel R. Major, Wolfgang Döhle, Ernest Hamel, Eric Ferrandis, Ann Fiore, Philip G. Kasprzyk, Barry V. L. Potter	2013	15
19	Activation of the human mdr1 gene promoter in differentiated neuroblasts International Journal of Cancer ·Eric Ferrandis, Jean Bénard	1993	14
20	BN82451 attenuates l-dopa-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson’s disease Neuropharmacology ·B. Spinnewyn, Gisèle Mautino, Jean‐Grégoire Marin, Marie Rocher, Anne Sophie Grandoulier, Eric Ferrandis, Michel Auguet, Pierre‐Etienne Chabrier	2010	12

About Eric Ferrandis

Eric Ferrandis is a scholar working on Molecular Biology, Organic Chemistry, Neurology, Cancer Research and Genetics, having authored 27 papers that have together received 761 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (6 papers), Synthesis and Biological Evaluation (6 papers), Estrogen and related hormone effects (5 papers), Synthesis and Biological Activity (4 papers), Ferrocene Chemistry and Applications (3 papers), Cancer Treatment and Pharmacology (3 papers), Cancer therapeutics and mechanisms (3 papers) and Synthesis and biological activity (3 papers). The work is most often cited by research in Toxicology (39 citations), Organic Chemistry (320 citations), Neurology (97 citations), Molecular Biology (412 citations) and Cancer Research (82 citations). Eric Ferrandis has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Barry V. L. Potter, Mathew P. Leese, Fabrice Jourdan, Atul Purohit, Wolfgang Döhle, Ernest Hamel, Simon P. Newman, Michael Reed, G Riou and Philip G. Kasprzyk. Their work appears in journals such as Journal of Medicinal Chemistry, ChemMedChem, Nature Medicine, Chemical Communications and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact